TY - JOUR
T1 - A point-based prediction model for cardiovascular risk in orthotopic liver transplantation
T2 - The CAR-OLT score
AU - VanWagner, Lisa B.
AU - Ning, Hongyan
AU - Whitsett, Maureen
AU - Levitsky, Josh
AU - Uttal, Sarah
AU - Wilkins, John T.
AU - Abecassis, Michael M.
AU - Ladner, Daniela P.
AU - Skaro, Anton I.
AU - Lloyd-Jones, Donald M.
N1 - Funding Information:
Received January 16, 2017; accepted June 20, 2017. Additional Supporting Information may be found at onlinelibrary.wiley.com/doi/10.1002/hep.29329/suppinfo. Supported by the National Institutes of Health (1 F32 HL116151-01), the American Liver Foundation, an Alpha Omega Alpha Postgraduate Award, and the National Institutes of Health’s National Center for Advancing Translational Sciences (KL2TR001424, to L.B.V.; UL1TR001422, to the Northwestern Medicine Enterprise Data Warehouse). Copyright VC 2017 by the American Association for the Study of Liver Diseases. View this article online at wileyonlinelibrary.com. DOI 10.1002/hep.29329
Publisher Copyright:
© 2017 by the American Association for the Study of Liver Diseases.
PY - 2017/12
Y1 - 2017/12
N2 - Cardiovascular disease (CVD) complications are important causes of morbidity and mortality after orthotopic liver transplantation (OLT). There is currently no preoperative risk-assessment tool that allows physicians to estimate the risk for CVD events following OLT. We sought to develop a point-based prediction model (risk score) for CVD complications after OLT, the Cardiovascular Risk in Orthotopic Liver Transplantation risk score, among a cohort of 1,024 consecutive patients aged 18-75 years who underwent first OLT in a tertiary-care teaching hospital (2002-2011). The main outcome measures were major 1-year CVD complications, defined as death from a CVD cause or hospitalization for a major CVD event (myocardial infarction, revascularization, heart failure, atrial fibrillation, cardiac arrest, pulmonary embolism, and/or stroke). The bootstrap method yielded bias-corrected 95% confidence intervals for the regression coefficients of the final model. Among 1,024 first OLT recipients, major CVD complications occurred in 329 (32.1%). Variables selected for inclusion in the model (using model optimization strategies) included preoperative recipient age, sex, race, employment status, education status, history of hepatocellular carcinoma, diabetes, heart failure, atrial fibrillation, pulmonary or systemic hypertension, and respiratory failure. The discriminative performance of the point-based score (C statistic = 0.78, bias-corrected C statistic = 0.77) was superior to other published risk models for postoperative CVD morbidity and mortality, and it had appropriate calibration (Hosmer-Lemeshow P = 0.33). Conclusion: The point-based risk score can identify patients at risk for CVD complications after OLT surgery (available at www.carolt.us); this score may be useful for identification of candidates for further risk stratification or other management strategies to improve CVD outcomes after OLT. (Hepatology 2017;66:1968–1979).
AB - Cardiovascular disease (CVD) complications are important causes of morbidity and mortality after orthotopic liver transplantation (OLT). There is currently no preoperative risk-assessment tool that allows physicians to estimate the risk for CVD events following OLT. We sought to develop a point-based prediction model (risk score) for CVD complications after OLT, the Cardiovascular Risk in Orthotopic Liver Transplantation risk score, among a cohort of 1,024 consecutive patients aged 18-75 years who underwent first OLT in a tertiary-care teaching hospital (2002-2011). The main outcome measures were major 1-year CVD complications, defined as death from a CVD cause or hospitalization for a major CVD event (myocardial infarction, revascularization, heart failure, atrial fibrillation, cardiac arrest, pulmonary embolism, and/or stroke). The bootstrap method yielded bias-corrected 95% confidence intervals for the regression coefficients of the final model. Among 1,024 first OLT recipients, major CVD complications occurred in 329 (32.1%). Variables selected for inclusion in the model (using model optimization strategies) included preoperative recipient age, sex, race, employment status, education status, history of hepatocellular carcinoma, diabetes, heart failure, atrial fibrillation, pulmonary or systemic hypertension, and respiratory failure. The discriminative performance of the point-based score (C statistic = 0.78, bias-corrected C statistic = 0.77) was superior to other published risk models for postoperative CVD morbidity and mortality, and it had appropriate calibration (Hosmer-Lemeshow P = 0.33). Conclusion: The point-based risk score can identify patients at risk for CVD complications after OLT surgery (available at www.carolt.us); this score may be useful for identification of candidates for further risk stratification or other management strategies to improve CVD outcomes after OLT. (Hepatology 2017;66:1968–1979).
UR - http://www.scopus.com/inward/record.url?scp=85034391954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85034391954&partnerID=8YFLogxK
U2 - 10.1002/hep.29329
DO - 10.1002/hep.29329
M3 - Article
C2 - 28703300
AN - SCOPUS:85034391954
SN - 0270-9139
VL - 66
SP - 1968
EP - 1979
JO - Hepatology
JF - Hepatology
IS - 6
ER -